Back
Intra-Cellular Therapies Stock Price Chart
Free Stock Analysis Report: See The True Value of Any Stock
Analyze Any Stock Free
Sell
42
ITCI
Intra-Cellular Therapies
Last Price:
$94.86
Seasonality Move:
2.9%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.68 | Buy |
| 20-day SMA: | 84.71 | Buy |
| 50-day SMA: | 85.48 | Buy |
| 200-day SMA: | 75.72 | Buy |
| 8-day EMA: | 85.91 | Buy |
| 20-day EMA: | 85.03 | Buy |
| 50-day EMA: | 83.75 | Buy |
| 200-day EMA: | 76.64 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.52 | Buy |
| Relative Strength Index (14 RSI): | 71.02 | Buy |
| Chaikin Money Flow: | 1717350 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.26 - 87.1) | Buy |
| Bollinger Bands (100): | (74.04 - 85.96) | Buy |
Intra-Cellular Therapies Technical Analysis
| Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
-
Intra-Cellular Therapies share price is 94.87 while ITCI 8-day simple moving average is 84.68, which is a Buy signal.
-
The stock price of ITCI is 94.87 while Intra-Cellular Therapies 20-day SMA is 84.71, which makes it a Buy.
-
Intra-Cellular Therapies 50-day simple moving average is 85.48 while ITCI share price is 94.87, making it a Buy technically.
-
ITCI stock price is 94.87 and Intra-Cellular Therapies 200-day simple moving average is 75.72, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Sell
42
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a SellThe current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
10.1B
Price in USD:
94.87
Share Volume:
4.1M
Intra-Cellular Therapies 52-Week Range
52-Week High:
98.40
52-Week Low:
62.78
Sell
42
Intra-Cellular Therapies (ITCI)
is a Sell
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?The Intra-Cellular Therapies stock price is 94.87 USD today.
-
Will ITCI stock go up or go down?Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators
-
Is Intra-Cellular Therapies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is overvalued.
Is Intra-Cellular Therapies Stock a Buy?
-
Intra-Cellular Therapies share price is 94.87 while ITCI 8-day exponential moving average is 85.91, which is a Buy signal.
-
The stock price of ITCI is 94.87 while Intra-Cellular Therapies 20-day EMA is 85.03, which makes it a Buy.
-
Intra-Cellular Therapies 50-day exponential moving average is 83.75 while ITCI share price is 94.87, making it a Buy technically.
-
ITCI stock price is 94.87 and Intra-Cellular Therapies 200-day simple moving average is 76.64, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
-
ITCI Moving Average Covergence Divergence (MACD) indicator is 0.52, suggesting Intra-Cellular Therapies is a Buy
-
Intra-Cellular Therapies Relative Strength Index (RSI) is 71.02, which suggest Intra-Cellular Therapies is overbought
-
The Bollinger Bands (25) for Intra-Cellular Therapies is (82.26 - 87.1), which suggest Intra-Cellular Therapies is a Buy
-
The Bollinger Bands (100) for Intra-Cellular Therapies is (74.04 - 85.96), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.